[Form 3] ReShape Lifesciences, Inc. Initial Statement of Beneficial Ownership
Venkateswarlu Nelabhotla filed an SEC Form 3 reporting his initial statement of beneficial ownership with respect to Vyome Holdings, Inc. (ticker HIND). The filing, tied to an event dated 08/15/2025, identifies him as both President & CEO and a director. The Form 3 states no securities are beneficially owned by the reporting person. The form is signed and dated 09/11/2025.
- None.
- None.
Insights
TL;DR: Initial ownership filing reports no securities held by the issuer's President & CEO—neutral disclosure.
The Form 3 documents an initial Section 16 filing for Vyome Holdings, Inc., naming Venkateswarlu Nelabhotla as President & CEO and director. Crucially, the filer indicates no beneficial ownership of the issuer's securities as of the reported event date. From a market-impact perspective, the disclosure itself is routine and provides transparency about insider holdings; it does not reveal transactions or holdings that would affect valuation or shareholder voting dynamics.
TL;DR: The filing fulfills Section 16 reporting requirements but contains no material ownership information.
The submission meets the regulatory requirement to disclose initial insider status and role (President & CEO; director). Reporting no beneficial ownership is notable for record-keeping but does not indicate any insider purchases, grants, or equity incentive exercises. For governance monitoring, this is a neutral data point: it documents officer/director status without disclosing equity interests or potential conflicts.